Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

informed patients

- PMLiVE

An exciting outlook for pre-approval access and compassionate use

How to deal with the ethical and practical considerations of the demand for promising new drugs that are in development

- PMLiVE

The new launch paradigm

The journey from capabilities excellence to effectiveness

Dispensing with the past

The pharma boards of the future

- PMLiVE

Why culture is too often the missing link in patient-centricity

Looking at the role culture plays in shaping attitudes and behaviour in healthcare

- PMLiVE

The Book of Boredom

Integrated communications might sound boring but it's a cause well worth believing in

- PMLiVE

Orphan drugs: Leading the way in patient-centricity

What lessons about optimal patient engagement can big pharma learn from those operating in rare disease?

Communicating with payers to improve patient access

A transforming NHS brings with it many opportunities. Working with payers to put patients at the heart of everything while reducing costs is fundamental to success.

- PMLiVE

Turning healthcare on its head

Efforts to deliver patient-centric care are turning healthcare communications on its head

- PMLiVE

UK to cut wait to innovative treatments by four years

Proposals in the Accelerated Access Review aim to speed up access to innovation

- PMLiVE

Pharma ‘could do better’ on social media engagement

Industry is comfortable with the tech but has work to do on its approach

- PMLiVE

Roche creates the Fight IPF choir for disease awareness campaign

Aims to raise the lung disease's profile and inform patients and their families

- PMLiVE

Time for a new language for asthma?

Many patients lack an understanding of what ‘control’ means

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links